Business

Pharma Inc gets back to life beyond Covid

By Dan Neff

In FY23, the company is targeting 130 drug launches in the emerging markets, of which 30 would be in India.

Synopsis

For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.

ET Intelligence Group: The June quarter results announced by three leading Indian pharma companies – Sun Pharma, Dr Reddy’s Labs (DRL) and Cipla – last week have some key takeaways for investors.

Normalisation of Covid revenues: The base quarter of June 2021 was impacted by the second wave of the Covid-19 pandemic with companies’ domestic market performance driven by the sale of Covid medication. That business has now gotten normalised. For

BY

ET Bureau

5 mins read, Last Updated:

  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

For all the latest Business News Click Here 

 For the latest news and updates, follow us on Google News. 

Read original article here

Denial of responsibility! TheDailyCheck is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.

Dan Neff